High-throughput technologies for studying potassium channels - Progresses and challenges

Jia Xu, Ying Chen, Min Li

Research output: Contribution to journalArticle

Abstract

Of the more than 400 ion channel genes in the human genome, at least 170 are known to encode potassium channels. Structural studies have provided atomic resolution of some potassium channels. In drug development, potassium channels have been both targets to focus upon and targets to avoid. The unique combination of functional and clinical attributes places potassium channels in an important position regarding both basic medical research and pharmaceutical therapeutics. This article discusses three topics: the biology of potassium channels, methods of detection, and challenges for detection assays and data interpretation.

Original languageEnglish (US)
Pages (from-to)32-38
Number of pages7
JournalDrug Discovery Today: TARGETS
Volume3
Issue number1
DOIs
StatePublished - Jan 2004

Fingerprint

Potassium Channels
Technology
Human Genome
Ion Channels
Pharmaceutical Preparations
Biomedical Research
Genes

ASJC Scopus subject areas

  • Drug Discovery

Cite this

High-throughput technologies for studying potassium channels - Progresses and challenges. / Xu, Jia; Chen, Ying; Li, Min.

In: Drug Discovery Today: TARGETS, Vol. 3, No. 1, 01.2004, p. 32-38.

Research output: Contribution to journalArticle

@article{2f9785de3b6845878cadf343a70a38fd,
title = "High-throughput technologies for studying potassium channels - Progresses and challenges",
abstract = "Of the more than 400 ion channel genes in the human genome, at least 170 are known to encode potassium channels. Structural studies have provided atomic resolution of some potassium channels. In drug development, potassium channels have been both targets to focus upon and targets to avoid. The unique combination of functional and clinical attributes places potassium channels in an important position regarding both basic medical research and pharmaceutical therapeutics. This article discusses three topics: the biology of potassium channels, methods of detection, and challenges for detection assays and data interpretation.",
author = "Jia Xu and Ying Chen and Min Li",
year = "2004",
month = "1",
doi = "10.1016/S1741-8372(04)02394-1",
language = "English (US)",
volume = "3",
pages = "32--38",
journal = "Drug Discovery Today: TARGETS",
issn = "1741-8372",
publisher = "Elsevier BV",
number = "1",

}

TY - JOUR

T1 - High-throughput technologies for studying potassium channels - Progresses and challenges

AU - Xu, Jia

AU - Chen, Ying

AU - Li, Min

PY - 2004/1

Y1 - 2004/1

N2 - Of the more than 400 ion channel genes in the human genome, at least 170 are known to encode potassium channels. Structural studies have provided atomic resolution of some potassium channels. In drug development, potassium channels have been both targets to focus upon and targets to avoid. The unique combination of functional and clinical attributes places potassium channels in an important position regarding both basic medical research and pharmaceutical therapeutics. This article discusses three topics: the biology of potassium channels, methods of detection, and challenges for detection assays and data interpretation.

AB - Of the more than 400 ion channel genes in the human genome, at least 170 are known to encode potassium channels. Structural studies have provided atomic resolution of some potassium channels. In drug development, potassium channels have been both targets to focus upon and targets to avoid. The unique combination of functional and clinical attributes places potassium channels in an important position regarding both basic medical research and pharmaceutical therapeutics. This article discusses three topics: the biology of potassium channels, methods of detection, and challenges for detection assays and data interpretation.

UR - http://www.scopus.com/inward/record.url?scp=10044275839&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10044275839&partnerID=8YFLogxK

U2 - 10.1016/S1741-8372(04)02394-1

DO - 10.1016/S1741-8372(04)02394-1

M3 - Article

VL - 3

SP - 32

EP - 38

JO - Drug Discovery Today: TARGETS

JF - Drug Discovery Today: TARGETS

SN - 1741-8372

IS - 1

ER -